The use of an intracoronary hemodynamic technique, such as FRACTIONAL FLOW RESERVE (FFR), to determine the severity of a stenosis, can help when deciding whether to perform percutaneous coronary ...

Do PCI 2.1/2.2 slots support both 5v and 3.3v signaling?<BR><BR>I was under the assumption that all conventional PCI devices were 5v only, but am now extremely confused at which specs support which ...

ORLANDO – November 4, 2021 – The FAVOR III China trial found that lesion selection for percutaneous coronary intervention (PCI) using the non-invasively assessed physiologic measurement quantitative ...

NEC is developing a system that can extend the conventional PCI Express interface found in most PCs and servers over standard Ethernet to distances of 2 kilometers or more. ExpEther, as the company ...

As data bandwidths escalate, the conventional-PCI shared-bus technology is too slow for many high-performance I/O applications. PCI Express promises to extend the life of PCI by providing a low-cost, ...

Primary percutaneous coronary intervention (PCI) is the standard treatment for ST-segment elevation myocardial infarction (STEMI). Although PCI is effective at opening the infarct-related artery, ...

AWANS, Belgium -- Miracor Medical SA (Miracor Medical) today announced the initiation and first patient enrollment in the PICSO-AMI-I study to evaluate the benefits of PiCSO® therapy compared with ...

Treating acute heart attack with thrombus aspiration (TA) results in improved 1-year clinical outcomes compared with the conventional treatment of percutaneous coronary intervention (PCI) alone. These ...

Subhash Banerjee, MD (VA North Texas Health Care System & UT Southwestern Medical Center, Dallas), who presented the results of the PREMIER trial in a featured clinical research session at the annual ...

The PCI Special Interest Group (PCI-SIG) today announced the release of the latest upgrade to the PCI specification. The PCI local bus spec v2.3 is the first major upgrade to conventional PCI since ...

AWANS, Belgium--(BUSINESS WIRE)--Miracor Medical SA (Miracor Medical) today announced the initiation and first patient enrollment in the PICSO-AMI-I study to evaluate the benefits of PiCSO ® therapy ...